0

Dyslipidemia Collection
 121-140 of 352 Articles
Editorials |  1 June 1997
Is Hypertriglyceridemia a Risk Factor for Atherosclerotic Cardiovascular Disease? A Simple Question with a Complicated Answer
Henry N. Ginsberg, MD
Ann Intern Med. 1997;126(11):912-914. doi:10.7326/0003-4819-126-11-199706010-00012
Articles |  15 May 1997
Clarifying the Direct Relation between Total Cholesterol Levels and Death from Coronary Heart Disease in Older Persons
Maria-Chiara Corti, MD, MHS; Jack M. Guralnik, MD, PhD; Marcel E. Salive, MD, MPH; et al.
Ann Intern Med. 1997;126(10):753-760. doi:10.7326/0003-4819-126-10-199705150-00001
Reviews |  15 December 1996
Dose-Response Characteristics of Cholesterol-Lowering Drug Therapies: Implications for Treatment
Gordon Schectman, MD; Jan Hiatt, PharmD
Ann Intern Med. 1996;125(12):990-1000. doi:10.7326/0003-4819-125-12-199612150-00011
Articles |  15 December 1996
Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease
Abraham A. Kroon, MD; Wim N.J.C. van Asten, PhD; Anton F.H. Stalenhoef, MD
Ann Intern Med. 1996;125(12):945-954. doi:10.7326/0003-4819-125-12-199612150-00001
Articles |  1 November 1996
Twenty-Year Dynamics of Serum Cholesterol Levels in the Middle-Aged Population of Eastern Finland
Pekka Jousilahti, MD, MSc; Erkki Vartiainen, MD, PhD; Jaakko Tuomilehto, MD, PhD, MPolSc; et al.
Ann Intern Med. 1996;125(9):713-722. doi:10.7326/0003-4819-125-9-199611010-00002
Ideas and Opinions |  1 October 1996
Surrogate End Points in Clinical Trials: Are We Being Misled?
Thomas R. Fleming, PhD; David L. DeMets, PhD
Ann Intern Med. 1996;125(7):605-613. doi:10.7326/0003-4819-125-7-199610010-00011
Articles |  1 October 1996
Effect of Combination Therapy with Lipid-Reducing Drugs in Patients with Coronary Heart Disease and “Normal” Cholesterol Levels: A Randomized, Placebo-Controlled Trial
Richard C. Pasternak, MD; Lisa E. Brown, MPH; Peter H. Stone, MD; et al.
Ann Intern Med. 1996;125(7):529-540. doi:10.7326/0003-4819-125-7-199610010-00001
Ideas and Opinions |  15 September 1996
Lowering Risk without Lowering Cholesterol: Implications for National Cholesterol Policy
Andrew L. Avins, MD, MPH; Warren S. Browner, MD, MPH
Ann Intern Med. 1996;125(6):502-506. doi:10.7326/0003-4819-125-6-199609150-00012
Editorials |  15 May 1996
Lipid Formulations for Amphotericin B: Does the Emperor Need New Clothes?
John R. Graybill, MD
Ann Intern Med. 1996;124(10):921-923. doi:10.7326/0003-4819-124-10-199605150-00011
Ideas and Opinions |  15 May 1996
Cholesterol Reduction: Weighing the Benefits and Risks
J. Michael Gaziano, MD, MPH; Patricia R. Hebert, PhD; Charles H. Hennekens, MD, DrPH
Ann Intern Med. 1996;124(10):914-918. doi:10.7326/0003-4819-124-10-199605150-00009
Articles |  15 March 1996
Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy: A Randomized, Controlled Clinical Trial
Howard N. Hodis, MD; Wendy J. Mack, PhD; Laurie LaBree, MS; et al.
Ann Intern Med. 1996;124(6):548-556. doi:10.7326/0003-4819-124-6-199603150-00002
Position Papers |  1 March 1996
CLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, Revisited
Alan M. Garber, MD, PhD; Warren S. Browner, MD, MPH; Stephen B. Hulley, MD, MPH
Ann Intern Med. 1996;124(5):518-531. doi:10.7326/0003-4819-124-5-199603010-00013
Position Papers |  1 March 1996
CLINICAL GUIDELINE, PART 1: Guidelines for Using Serum Cholesterol, High-Density Lipoprotein Cholesterol, and Triglyceride Levels as Screening Tests for Preventing Coronary Heart Disease in Adults
American College of Physicians*
Ann Intern Med. 1996;124(5):515-517. doi:10.7326/0003-4819-124-5-199603010-00012
Editorials |  1 March 1996
Evangelists and Snails Redux: The Case of Cholesterol Screening
Frank Davidoff, MD
Ann Intern Med. 1996;124(5):513-514. doi:10.7326/0003-4819-124-5-199603010-00011
Ideas and Opinions |  1 March 1996
Cholesterol Agonistics
John C. LaRosa, MD
Ann Intern Med. 1996;124(5):505-508. doi:10.7326/0003-4819-124-5-199603010-00008
Brief Communications |  15 February 1996
Hyperlipidemia and Pancreatitis during Pregnancy in Two Sisters with a Mutation in the Lipoprotein Lipase Gene
Leonard M. Keilson, MD, MPH; Calvin P.H. Vary, PhD; Dennis L. Sprecher, MD; et al.
Ann Intern Med. 1996;124(4):425-428. doi:10.7326/0003-4819-124-4-199602150-00007
Articles |  15 December 1995
Effects of n-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension: A Randomized, Controlled Trial
Ingrid Toft, MD; Kaare H. Bonaa, MD, PhD; Ole C. Ingebretsen, MD, PhD; et al.
Ann Intern Med. 1995;123(12):911-918. doi:10.7326/0003-4819-123-12-199512150-00003
Articles |  1 October 1995
Combination Therapy with Colestipol and Psyllium Mucilloid in Patients with Hyperlipidemia
J. David Spence, MD; Murray W. Huff, PhD; Paul Heidenheim, MA; et al.
Ann Intern Med. 1995;123(7):493-499. doi:10.7326/0003-4819-123-7-199510010-00003
Brief Communications |  1 May 1995
Effects of Alcohol and Fluvastatin on Lipid Metabolism and Hepatic Function
Jan W. Smit, MD; Herman J. Wijnne, PhD; Fred Schobben, PhD; et al.
Ann Intern Med. 1995;122(9):678-680. doi:10.7326/0003-4819-122-9-199505010-00006
Reviews |  15 January 1995
Effects of Antihypertensive Therapy on Serum Lipids
Bertram L. Kasiske, MD; Jennie Z. Ma, MS; Roberto S. N. Kalil, MD; et al.
Ann Intern Med. 1995;122(2):133-141. doi:10.7326/0003-4819-122-2-199501150-00010
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)